End-Tidal CO₂ Monitoring in Intubated Adults
Target normocapnia with end-tidal CO₂ of 35-45 mmHg (4.7-6.0 kPa) in mechanically ventilated adults, and always confirm this with arterial blood gas measurements rather than relying on ETCO₂ alone for ventilation management. 1
Target Values
The most recent European Resuscitation Council guidelines (2025) provide clear targets for mechanically ventilated patients:
- Normal range: 35-45 mmHg (4.7-6.0 kPa) 1
- This applies specifically to adults with return of spontaneous circulation after cardiac arrest
- The goal is normocapnia—avoiding both hypocapnia and hypercapnia
For prehospital and emergency intubation, aim for normocapnia equivalent to ETCO₂ of 4.0-4.5 kPa 2
Critical Monitoring Requirements
Always obtain arterial blood gases in addition to monitoring ETCO₂ 1. This is essential because:
- ETCO₂ correlates poorly with actual PaCO₂ in critically ill patients (R² = 0.14 in one study) 3
- Trauma patients show particularly poor correlation, especially those with impaired tissue perfusion 4
- Patients ventilated to "normal" ETCO₂ (35-40 mmHg) were actually hypoventilated (PaCO₂ >40) 80% of the time 4
Management of Abnormal Readings
Low ETCO₂ (<30-35 mmHg)
Low ETCO₂ indicates either inadequate cardiac output or hyperventilation:
- In cardiac arrest: ETCO₂ <10 mmHg suggests inadequate CPR quality and low probability of survival 5, 6
- In intubated trauma patients: ETCO₂ ≤28 mmHg associated with 55% mortality vs 17% with higher values 3
- Action steps:
- Check arterial blood gas immediately to determine true PaCO₂
- If PaCO₂ is also low: reduce minute ventilation
- If PaCO₂ is normal/high despite low ETCO₂: this indicates V/Q mismatch, poor perfusion, or increased dead space
- Address underlying perfusion issues (fluid resuscitation, vasopressors as needed)
- Aim to maintain ETCO₂ ≥29 mmHg and arterial-to-ETCO₂ gradient ≤7 mmHg 3
High ETCO₂ (>45 mmHg)
High ETCO₂ suggests hypoventilation:
- Verify with arterial blood gas
- Increase minute ventilation (increase respiratory rate or tidal volume)
- Check for equipment malfunction or circuit issues
- In hypothermic patients, monitor PaCO₂ frequently as hypocapnia may occur despite normal ETCO₂ 1
Sudden Increase in ETCO₂
An abrupt sustained increase to 35-40 mmHg during CPR indicates return of spontaneous circulation 5, 7. This is a reliable indicator of ROSC and should prompt rhythm assessment.
Special Populations
Post-Cardiac Arrest
- Target normocapnia: 35-45 mmHg 1
- Use lung-protective ventilation: 6-8 mL/kg ideal body weight 1
- Monitor frequently if hypothermia is used
Trauma Patients
- Do not rely on ETCO₂ alone—correlation with PaCO₂ is particularly poor 4
- Nearly 50% of prehospital intubated patients arrive with abnormal ETCO₂ 8
- Abnormal initial ETCO₂ associated with 6-fold increased mortality risk 8
COPD/Hypercapnic Patients
- Use supplemental oxygen cautiously 9
- Monitor blood or ETCO₂ levels whenever possible 9
- Assess whether hypoxemia is due to hypoventilation, atelectasis, or secretions 9
Common Pitfalls
- Assuming ETCO₂ equals PaCO₂: The arterial-to-ETCO₂ gradient can be substantial, especially in critically ill patients with V/Q mismatch
- Ignoring sudden changes: Abrupt increases suggest ROSC; sudden decreases may indicate circuit disconnect, tube displacement, or cardiovascular collapse
- Over-reliance in trauma: ETCO₂ has the worst correlation in patients with poor tissue perfusion 4
- Not accounting for vasopressors: High-dose epinephrine can transiently decrease ETCO₂ despite adequate CPR 5
- Ignoring sodium bicarbonate effect: Bicarbonate administration causes transient ETCO₂ increase that doesn't reflect improved perfusion 5
Practical Algorithm
- Initial setup: Confirm tube placement with waveform capnography 1, 2
- Set initial ventilation: Target ETCO₂ 35-45 mmHg
- Obtain arterial blood gas within 30-60 minutes 1
- Adjust ventilation based on PaCO₂, not ETCO₂ alone
- Recheck blood gases after any significant change in ventilator settings or clinical status
- Monitor ETCO₂ trends for sudden changes indicating clinical events